Efficacy of pemetrexed plus platinum doublet chemotherapy as first-line treatment for advanced nonsquamous non-small-cell-lung cancer: a systematic review and meta-analysis

OncoTargets and Therapy ◽

10.2147/ott.s96160 ◽

2016 ◽

pp. 1471 ◽

Author(s):

Yi-Ming Ni ◽

Huai-Qing Xiao ◽

Rong-Hua Tian ◽

Zhi-Hao Zhang ◽

Kai-Qi Du

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Meta Analysis ◽

Line Treatment ◽

Small Cell Lung ◽

Doublet Chemotherapy ◽

First Line Treatment ◽

Platinum Doublet

Download Full-text

PCN183 A Cost-Effectiveness Analysis of Nivolumab plus Ipilimumab plus Two Cycles of Platinum Doublet-Chemotherapy Versus Platinum Doublet Chemotherapy in the First-Line Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer in Canada

Value in Health ◽

10.1016/j.jval.2021.04.274 ◽

2021 ◽

Vol 24 ◽

pp. S53

Author(s):

K.C. Young ◽

H. Sandhu ◽

A. Lee ◽

K. Lakhdari ◽

J. Maervoet ◽

...

Keyword(s):

Lung Cancer ◽

Stage Iv ◽

Line Treatment ◽

Small Cell Lung ◽

Effectiveness Analysis ◽

Doublet Chemotherapy ◽

First Line Treatment ◽

Platinum Doublet

Download Full-text

Doublet Versus Single Cytotoxic Agent as First-Line Treatment for Elderly Patients with Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

Lung ◽

10.1007/s00408-012-9399-3 ◽

2012 ◽

Vol 190 (5) ◽

pp. 477-485 ◽

Author(s):

Wei-Xiang Qi ◽

Li-na Tang ◽

Ai-na He ◽

Zan Shen ◽

Feng Lin ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Meta Analysis ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis

Lung Cancer ◽

10.1016/j.lungcan.2019.05.029 ◽

2019 ◽

Vol 134 ◽

pp. 127-140 ◽

Author(s):

Urania Dafni ◽

Zoi Tsourti ◽

Katerina Vervita ◽

Solange Peters

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

Platinum-doublet chemotherapy as second-line treatment for relapsed patients with small-cell lung cancer: a systematic review and meta-analysis

Lung Cancer ◽

10.1016/j.lungcan.2021.04.013 ◽

2021 ◽

Author(s):

Kohei Horiuchi ◽

Takashi Sato ◽

Toshiki Kuno ◽

Hisato Takagi ◽

Fred R. Hirsch ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Meta Analysis ◽

Line Treatment ◽

Second Line ◽

Small Cell Lung ◽

Doublet Chemotherapy ◽

Platinum Doublet

Download Full-text

O14‐2: Chemotherapy versus chemo‐immunotherapy as first‐line treatment in patients with extensive‐stage small‐cell lung cancer‐A systematic review and meta‐analysis

Respirology ◽

10.1111/resp.14149_81 ◽

2021 ◽

Vol 26 (S3) ◽

pp. 38-39

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Meta Analysis ◽

Line Treatment ◽

Small Cell Lung ◽

Extensive Stage ◽

First Line Treatment

Download Full-text

Efficacy and safety of PD‐1/PD‐L1 inhibitor plus chemotherapy versus chemotherapy alone as first‐line treatment for extensive‐stage small cell lung cancer: A systematic review and meta‐analysis

Thoracic Cancer ◽

10.1111/1759-7714.13698 ◽

2020 ◽

Vol 11 (12) ◽

pp. 3536-3546

Author(s):

Shuang Zhang ◽

Shuang Li ◽

Ying Cheng

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Meta Analysis ◽

Line Treatment ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Extensive Stage ◽

First Line Treatment

Download Full-text

Crizotinib Versus Conventional Chemotherapy in First-Line Treatment for ALK-Positive Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

Oncology and Therapy ◽

10.1007/s40487-021-00155-3 ◽

2021 ◽

Author(s):

Barbara D. Cruz ◽

Mariana M. Barbosa ◽

Lucas L. Torres ◽

Pamela S. Azevedo ◽

Vânia E. A. Silva ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Meta Analysis ◽

Line Treatment ◽

Small Cell Lung ◽

Conventional Chemotherapy ◽

Alk Positive ◽

First Line Treatment

Download Full-text

First-line treatment options for advanced non-small cell lung cancer patients with PD-L1 ≥ 50%: a systematic review and network meta-analysis

Cancer Immunology Immunotherapy ◽

10.1007/s00262-021-03089-x ◽

2021 ◽

Author(s):

Mingfeng He ◽

Taihao Zheng ◽

Xiaoyue Zhang ◽

Yuan Peng ◽

Xuan Jiang ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Meta Analysis ◽

Treatment Options ◽

Line Treatment ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

First Line Treatment

Download Full-text

Comparing single-agent with doublet chemotherapy in first-line treatment of advanced non-small cell lung cancer with performance status 2: A meta-analysis

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/ajco.12359 ◽

2015 ◽

Vol 11 (3) ◽

pp. 253-261 ◽

Author(s):

Long Luo ◽

Qian Hu ◽

Jun-xia Jiang ◽

Xing Yang ◽

Xiao-xiao Dinglin ◽

...

Keyword(s):

Lung Cancer ◽

Meta Analysis ◽

Performance Status ◽

Single Agent ◽

Line Treatment ◽

Small Cell Lung ◽

Doublet Chemotherapy ◽

First Line Treatment

Download Full-text

Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer

Annals of Oncology ◽

10.1093/annonc/mdt075 ◽

2013 ◽

Vol 24 (4) ◽

pp. 1133

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Meta Analysis ◽

Line Treatment ◽

Small Cell Lung ◽

Platinum Based Chemotherapy ◽

First Line Treatment

Download Full-text